Compare ConocoPhillips (COP) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Smith & Nephew plc — how do they compare? ConocoPhillips trades at $126 (market cap $151.27B), while Smith & Nephew plc trades at $29.77 (market cap $12.54B). The key difference: ConocoPhillips is far larger — about 12.1× Smith & Nephew plc's market cap, and ConocoPhillips pays the higher dividend (2.67%). Which is the better fit depends on your goals.
| COP | SNN | |
|---|---|---|
Market Cap | $151.27B | $12.54B |
Sector | Energy | Health |
52-Week High | $133.80 | $38.70 |
52-Week Low | $85.66 | $28.73 |
Enterprise Value | $166.87B | $15.57B |
Dividend Yield | 2.67% | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $125.75, up 2.21% on the day, with a bullish technical signal and strong Q2 2026 earnings beats. The stock shows robust fundamentals with a P/E of 16.66, ROE of 14.14%, and positive free cash flow trends. Recent news highlights CEO succession and operational strength, with analyst consensus strongly favoring a buy rating.
Outlook remains positive driven by high cash flow generation and favorable oil price trends, though risks include commodity price volatility and execution of major projects. The consensus price target of $150 suggests significant upside potential from current levels.
Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.
While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
